Explore all probiotics

Uses pili-mediated gut adhesion and soluble immune factors to shorten infectious diarrhea in children and reduce antibiotic-associated diarrhea, with RCT and meta-analysis support.

Stimulates NK cell activity via IL-12 signaling to reduce upper respiratory tract infection risk, supported by multiple RCTs.

Uses lactase production and bile salt hydrolase activity to improve lactose digestion and lipid profiles, with RCT evidence.

Uses mannose-specific gut adhesion to reduce IBS symptoms and improve iron status in deficient athletes, with RCT support.

Reference genome strain used to define L. plantarum genetics and host interaction mechanisms, with no direct human clinical evidence.

Uses adhesion and bacteriocin production to reduce H. pylori colonization and support gut barrier function, with RCT evidence.

Uses antimicrobial compounds and gut motility modulation to reduce infant colic crying time, with RCT and meta-analysis support.

Produces biosurfactants that inhibit vaginal pathogens to restore and maintain healthy vaginal flora, with RCT evidence.

Stimulates immune components in breast milk to reduce infant infections, with RCT support.

Uses fatty acid metabolism modulation to reduce abdominal adiposity and improve H. pylori-associated dyspepsia, with human RCT support.

Uses gut barrier modulation and neuroactive metabolites to reduce antibiotic-associated diarrhea and anxiety symptoms, with RCT evidence.

Uses gut colonization and immune signaling to reduce infectious diarrhea in children and support gut barrier development, with RCT evidence.

Produces bacteriocin ABP-118 to inhibit pathogens and modulate mucosal immunity, with IBD model evidence.

Produces bacteriocins and thrives in respiratory and food matrices, with potential for sinus microbiome applications.

Adheres to vaginal epithelial cells to displace pathogenic bacteria and reduce recurrent bacterial vaginosis, with RCT evidence.

Uses cell wall polysaccharides to modulate immunity and reduce IBS symptoms, with RCT evidence.

Produces lactic acid to ferment milk and support lactose digestion as a yogurt starter culture.

Produces lactase to improve lactose digestion and supports gut barrier function as a yogurt starter.

Consumes human milk oligosaccharides to produce anti-inflammatory metabolites, reducing IBS symptoms with RCT support.

Uses gut adhesion and bifidogenic metabolites to reduce antibiotic-associated diarrhea and support infant gut development, with RCT evidence.

Modulates gut transit time and immune cell activity to improve constipation and reduce infections, with RCT support.

Uses immune modulation to reduce allergic sensitization and respiratory symptoms in children, with RCT evidence.

Uses competitive pathogen exclusion and immune modulation to reduce infections and allergy symptoms, with RCT support.

Supports gut microbiome development in preterm infants as part of multi-strain formulations, with RCT evidence.

Produces nisin and serves as a genetic chassis for therapeutic protein delivery, with food preservation and vaccine applications.

Uses spore-based survival and protease production to improve protein absorption and reduce exercise-induced muscle damage, with RCT evidence.

Uses spore germination in the small intestine and bile salt hydrolase activity to improve blood lipids and gut barrier function, with RCT evidence.

Uses protease-mediated toxin degradation and pathogen inhibition to reduce antibiotic-associated diarrhea and support H. pylori eradication, with meta-analysis support.

Uses type 1 fimbriae and microcins to competitively exclude pathogens and maintain ulcerative colitis remission, with RCT evidence.

Uses immune modulation to reduce eczema prevalence through age 11 and improve postpartum mental health, with long-term RCT support.